Medicine
Alogliptin 25 mg tablet
Alogliptin 25 mg tablet is a generic prescription medicine for oral use, made by 4 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 25°C (77°F), excursions permitted to 15° to 30°C (59° to 86°F).
Key facts
- Active ingredient (INN)
- Alogliptin
- Brand
- Sold under the generic name
- Strength
- 25 mg
- Dosage form
- Tablet
- Route
- Oral
- Packs
- 30 tablets, 9000 tablets, 3000 tablets and 3 more
- Manufacturers
- Aphena Pharma Solutions - TennesseeA-S Medication SolutionsBryant Ranch PrepackPadagis Israel Pharmaceuticals
- Origin register
- US FDA, United States
- Storage
- Store at 25°C (77°F), excursions permitted to 15° to 30°C (59° to 86°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- A10BH04 Alogliptin
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 8 April 2016
- Identifiers
- RxCUI 1368006, 1368018, 1368034DailyMed set ID b25f155a-1259-47c2-aa3b-7c1356e4c7f6, 4b007011-547a-498e-b8f6-34ea4ea00eb4, 38d30e4f-4212-4f7a-96b5-74b277b56cba +1NDC 45802-150, 71610-300, 50090-5574 +1Application NDA022271
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Packs from every labeler of this generic presentation.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 30 tablet, film coated in 1 bottle | 45802-150-65 | Padagis Israel Pharmaceuticals | 8 April 2016 |
| 30 tablet, film coated in 1 bottle | 50090-5574-0 | A-S Medication Solutions | 2 July 2021 |
| 9000 tablet, film coated in 1 bottle | 71610-300-09 | Aphena Pharma Solutions - Tennessee | 3 July 2019 |
| 3000 tablet, film coated in 1 bottle | 71610-300-18 | Aphena Pharma Solutions - Tennessee | 25 January 2022 |
| 90 tablet, film coated in 1 bottle | 71610-300-60 | Aphena Pharma Solutions - Tennessee | 2 February 2023 |
| 30 tablet, film coated in 1 bottle | 63629-4946-1 | Bryant Ranch Prepack | 28 January 2025 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Alogliptin 25 mg tablet.
Other strengths and forms of Alogliptin
Clinical summary
Alogliptin is a dipeptidyl peptidase 4 inhibitor indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. It is available as tablets for oral use. MedsAcross supplies Alogliptin for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about AlogliptinFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Alogliptin prescribing information (Padagis Israel Pharmaceuticals) · U.S. National Library of Medicine, DailyMed
- Vipidia: European public assessment report (EPAR) · European Medicines Agency
Need Alogliptin 25 mg tablet for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.